February 24, 2014
Authored and Edited by B. Brett Heavner
On January 10, 2014, the Supreme Court agreed to hear the appeal in POM Wonderful v Coca-Cola. This case explores the tension between how the FDA [Food and Drug Administration] deals with factual statements on labelling versus how the Lanham Act, which governs trade mark law and false advertising law, deals with factual statements on labelling. At trial and then on appeal, the courts below took the view that the mere existence of specific regulations by the FDA relating to labelling preempts the ability of a private company to sue for false statements in the labelling under the Lanham Act. The Supreme Court will determine whether that is a correct interpretation of the FDA regulations.
The case involves a dispute between Coca-Cola's Minute Maid group and POM Wonderful relative to a Minute Made fruit beverage labelled as “pomegranate and blueberry” although made primarily from apple juice. FDA regulations allow juices to feature the principle flavoring element on the label, even where a beverage is not comprised primarily of that juice.
Whereas POM Wonderful contends that FDA rules should not protect a confusing or misleading lay out or label, Minute Maid takes the position that FDA rules should be a complete defense to the labelling of its beverage.
The key question raised in the appeal is whether a Lanham Act suit contesting the truth of labelling that complies with FDA regulations amounts to an attempt at private enforcement of FDA regulations or, alternatively, an attempt to second guess FDA regulations. If the latter, the Lanham Act false advertising claim may be pre-empted.
A decision by the Supreme Court’s decision could lay the groundwork for determining when a Lanham Act false-advertising claim can move forward in the face of regulation in that same field. The decision is likely to have significant impact not only on the pharmaceutical and food and beverage industry, but also on other industries where the government regulates advertising and labelling. Stay tuned.
Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
INCONTESTABLE® Blog
Courts and Legislators Addressing the Right of Publicity in the Age of AI
April 30, 2024
INCONTESTABLE® Blog
April 19, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.